Guardant Health (GH) Tops Q1 EPS by 26c, Updates Guidance

Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.49), $0.26 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $203.5 million versus the consensus estimate of $190.01 million.

GUIDANCE:

Guardant Health sees FY2025 revenue of $880-890 million, versus the consensus of $857.7 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41